Several tumor models were selected on the basis of a wide range of COX2 pathway activity, determined by measuring PGE2 levels in the supernatant of cultured tumor cells and PGEM levels in urine of tumor-bearing mice (Fig. 4A and B). Here, PTGS2 is linked to neoplasm.